IL6 and cardiovascular disorder: HS‐CRP diagnoses a low‐grade inflammation and is used as a potential biomarker for predicting cardiovascular disease risk, although IL‐6 also may have a prognostic role in subclinical cardiovascular events in high‐risk patients.16, 50